Understanding injuries in professional women's ice hockey
Official title: Swedish Female Ice Hockey Injury Study
Run by Lund University · NCT06351618 · Data updated 2026-11-12
This study looks at the types of injuries that professional women ice hockey players get when body checking to find ways to help them stay safer and healthier on the ice.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years to 110 Years |
| Sex | Women only |
| Enrollment | 225 (estimated) |
| Sponsor | Lund University Academic / other |
| Locations | 1 site (Malmö) |
| Status | Recruiting |
| Started | December 1, 2023 |
| Main results expected | March 26, 2024 |
| Study ends | January 1, 2028 |
| Registry record updated | April 8, 2024 |
| Trial ID | NCT06351618 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are female athletes aged 16 and older who are registered players in the highest Swedish professional ice hockey league.
✕Probably not a fit
Patients under the age of 16 will not benefit from this study as they are excluded from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational research project aims to analyze injury patterns among professional female ice hockey players who are permitted to body check. By identifying common injury types and mechanisms, the study seeks to enhance diagnosis and management strategies for these athletes. The findings could inform preventative measures in coaching, rule enforcement, and equipment improvements, ultimately aiming to reduce the incidence and severity of sports-related injuries. This research addresses a significant gap in sports medicine, focusing on female athletes in a high-risk sport.
Why it matters
Potential benefit: If successful, this study could lead to improved injury prevention strategies and better health outcomes for female ice hockey players.
How similar studies have gone: While there is limited research specifically on female ice hockey injuries, studies on injury epidemiology in other sports have shown success in informing prevention strategies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * minimum 16 years of age, registered player in the highest Swedish professional ice hockey league for women, SDHL Exclusion Criteria: * age under 16 years.
Where it's running
-
The Faculty of Medicine at Lund University
Malmö, Sweden Recruiting
Study contacts
- Study coordinator: Amanda Lahti
- Email: amanda.lahti@med.lu.se
- Phone: 0704854798
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Plan B and heart health: a look at how a single dose affects veins and arteries in young women
This study tests whether a single dose of Plan B® affects the blood vessels and heart health of healthy premenopausal women aged 18-35, by comparing it to a placebo in a short-term, double-blind setup.
-
Probiotic mix to see if it boosts fullness in adults who are overweight or have obesity
A probiotic supplement is being tested in adults aged 20-70 who are overweight or have obesity to see if it makes them feel fuller and changes gut bacteria harder after 16 weeks, compared with a placebo.
-
Fluorocholine PET/MR imaging in breast cancer patients before treatment
This study tests whether pre-treatment FCH PET/MR imaging markers can help predict breast cancer subtypes and likely outcomes in women.
-
Age-related facial skin structure in Chinese women measured with line-field confocal OCT
This project will use a safe, non-invasive imaging method to see how facial skin structure changes with age in Chinese women aged 20 to 70.
-
Transanal versus Transvaginal rectal resection for anterior rectocele
This project will test two surgical techniques—stapled transanal and stapled transvaginal rectal resection—to see which better relieves obstructed defecation in women with anterior rectocele.
-
Dostarlimab with cisplatin, etoposide, and radiotherapy for small cell neuroendocrine cervical cancer
This trial will test whether adding the immunotherapy drug dostarlimab to cisplatin/etoposide chemotherapy plus radiotherapy helps women with small cell neuroendocrine cervical carcinoma stay progression-free longer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.